Lifespan Edge, a next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, has announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland, with a third premier destination planned for Scottsdale, Arizona. The expansion marks a significant step in making personalized, evidence-based longevity care more accessible, following the company's founding in 2024 with a mission to bridge cutting-edge longevity research with individualized clinical care.
Dr. Michael Roizen, Chair of the Board and Co-Founder of Lifespan Edge, emphasized the importance of proactive healthcare. "Healthcare should not begin when disease appears, it should begin decades earlier," he said. "Our goal is to help people understand that many of the factors influencing how they age are modifiable. Through personalized care, informed lifestyle choices, and emerging scientific advances, we believe individuals can take greater control of their long-term health."
The new locations include 2528 Okeechobee Blvd. in West Palm Beach, FL 33409, and 10700 Charter Drive, Suite 200 in Columbia, MD 21044. A forthcoming Scottsdale, Arizona location is designed as a premier luxury wellness destination to serve clients from across the United States and abroad. Each clinic offers a concierge-style experience combining advanced diagnostics, physician-guided evaluations, and personalized strategies focused on prevention, performance, and healthy aging.
Interest in longevity medicine has accelerated as consumers seek proactive approaches to maintaining cognitive function, metabolic health, and physical resilience. Lifespan Edge emphasizes early risk identification and individualized plans rather than treating disease after symptoms arise. John Mauldin, President and Co-Founder, views this as a fundamental healthcare evolution. "We founded Lifespan Edge because we saw an opportunity to bring together leading physicians, science-driven medicine, and personalized care under one roof," he said. "As longevity research continues to advance, we want our clinics to help translate that science into practical strategies that empower people to live healthier, more productive lives."
Among the scientific areas attracting interest is Therapeutic Plasma Exchange (TPE), a medical procedure with established clinical uses being investigated for potential applications in aging and neurodegenerative disease. Notable research includes the AMBAR (Alzheimer Management by Albumin Replacement) clinical trial, which evaluated plasma exchange with albumin replacement in patients with mild-to-moderate Alzheimer’s disease. Published findings reported promise in slowing decline in certain cognitive and functional measures, though investigators emphasized that additional research is needed.
Dr. Roizen highlighted the broader significance of emerging therapies. "The most exciting developments in longevity are helping us better understand how the body repairs itself and how interventions may support healthier aging," he said. "Our philosophy is to follow the science, personalize care, and continually evaluate new evidence as it emerges." He has long advocated that biological age and chronological age are not always the same, and that lifestyle choices—including nutrition, physical activity, stress management, purpose, and social connection—can meaningfully influence long-term health.
With additional locations planned, Lifespan Edge aims to help redefine aging by bringing together physician expertise, advanced diagnostics, and evolving longevity science. The expansion into Florida, Maryland, and soon Arizona represents an important step toward making sophisticated longevity care available to more communities. The company's leadership has gained national recognition, with Dr. Roizen recently featured in Entrepreneur and TopDoctor Magazine, where he discussed the potential for healthier, more vital aging as research continues to advance.
